Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints
2016 · Nature Communications · 1,522 citations
https://doi.org/10.1038/ncomms10501
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
43
Papers
3.5K
Citations
17
h-index
19
i10-index
Meghana Kulkarni is an academic researcher. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Bioinformatics and Genomic Networks & interferon and immune responses. The author has an h-index of 17, co-authored 37 publications.
https://doi.org/10.1038/ncomms10501
https://doi.org/10.1002/jcb.20352
https://doi.org/10.1016/j.celrep.2016.08.029
https://doi.org/10.1038/srep20471
https://doi.org/10.1016/j.cmet.2005.04.008
https://doi.org/10.70534/uygr7013
Click to start Chat